Granisetron CAS：109889-09-0

2025-3-22

Granisetron CAS:109889-09-0 Product Guide

This comprehensive guide provides an in-depth analysis of Granisetron CAS:109889-09-0, a crucial medication used in the treatment of nausea and vomiting. The article aims to offer a clear understanding of the product's parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs. By the end of this guide, readers will have a comprehensive understanding of Granisetron CAS:109889-09-0 and its applications.

Abstract

This guide aims to provide a detailed overview of Granisetron CAS:109889-09-0, a medication used for the treatment of nausea and vomiting. The article covers various aspects such as product parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs. By the end of the guide, readers will have a comprehensive understanding of Granisetron CAS:109889-09-0 and its applications.

Product Parameters

Granisetron CAS:109889-09-0 is a selective serotonin receptor antagonist used for the prevention and treatment of nausea and vomiting associated with cancer chemotherapy, surgery, and radiation therapy. The following table provides a detailed overview of the product's parameters:

Parameter	Description
Chemical Name	Granisetron hydrochloride
Formula	C₂₀H₂₄N₄O₃·HCl
Molecular Weight	387.89 g/mol
Appearance	White to off-white crystalline powder
Solubility	Soluble in water, sparingly soluble in ethanol, and practically insoluble in chloroform

Usage Scenarios

Granisetron CAS:109889-09-0 is primarily used in the following scenarios:

Cancer chemotherapy: Granisetron is used to prevent nausea and vomiting associated with cancer chemotherapy.
Surgery: It is used to prevent nausea and vomiting after surgery.
Radiation therapy: Granisetron is used to prevent nausea and vomiting associated with radiation therapy.

Usage Cases

Here are two real-life usage cases of Granisetron CAS:109889-09-0:

Case 1: A 65-year-old patient with lung cancer received chemotherapy treatment. The patient experienced severe nausea and vomiting, which was effectively controlled with Granisetron CAS:109889-09-0.
Case 2: A 45-year-old patient underwent abdominal surgery and experienced postoperative nausea and vomiting. The patient was administered Granisetron CAS:109889-09-0, which helped alleviate the symptoms.

Solutions

Granisetron CAS:109889-09-0 offers several solutions for nausea and vomiting:

Prevention of nausea and vomiting during cancer chemotherapy, surgery, and radiation therapy.
Alleviation of nausea and vomiting symptoms in patients with gastrointestinal disorders.
Management of nausea and vomiting in pregnant women.

Expert Opinions

Experts recommend the following when using Granisetron CAS:109889-09-0:

Follow the prescribed dosage and duration of treatment.
Monitor for any adverse reactions and report them to the healthcare provider.
Do not exceed the recommended dosage to avoid potential side effects.

FAQs

Here are some frequently asked questions about Granisetron CAS:109889-09-0:

Q: What is Granisetron CAS:109889-09-0 used for?

A: Granisetron CAS:109889-09-0 is used for the prevention and treatment of nausea and vomiting associated with cancer chemotherapy, surgery, and radiation therapy.
Q: Are there any side effects of Granisetron CAS:109889-09-0?

A: Yes, Granisetron CAS:109889-09-0 may cause side effects such as constipation, headache, and dizziness. However, these side effects are usually mild and transient.
Q: Can Granisetron CAS:109889-09-0 be used during pregnancy?

A: Granisetron CAS:109889-09-0 should be used during pregnancy only if prescribed by a healthcare provider.

Summary

Granisetron CAS:109889-09-0 is a valuable medication used for the prevention and treatment of nausea and vomiting. This guide has provided a comprehensive overview of the product's parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs. By understanding the various aspects of Granisetron CAS:109889-09-0, healthcare providers and patients can make informed decisions regarding its use.